mp:VDraft3.0 kwalificatie medicatiegegevens TA addendum: verschil tussen versies
(init) |
|||
Regel 17: | Regel 17: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|3|| Maak screenshot(s) van de TA waaruit blijkt dat een aanvullende instructie, en gebruiksinstructie zo nodig correct wordt verwerkt/getoond.|| De TA die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_TA | |3|| Maak screenshot(s) van de TA waaruit blijkt dat een aanvullende instructie, en gebruiksinstructie zo nodig correct wordt verwerkt/getoond.|| De TA die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_TA | ||
+ | |-style="vertical-align:top;|style="background-color: white;" | ||
+ | |4|| Maak screenshot(s) van de TA waaruit blijkt dat de gebruiksinstructie correct wordt verwerkt/getoond.|| De parallelle TA's die worden aangemaakt in script 4|| MBH_300_script4|| MBH_300_script4_TA_GDS<br/>MBH_300_script4_TA_los | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|5|| Laat zien dat de TA gestaakt wordt door de stop-TA|| De TA bouwstenen van kwalificatiescript 5 Financiële Indicatiecode bij het staken van TA.|| MBH_300_SCRIPT5|| MBH_300_SCRIPT5_TA_STAKEN<br/>MBH_300_SCRIPT5_TA | |5|| Laat zien dat de TA gestaakt wordt door de stop-TA|| De TA bouwstenen van kwalificatiescript 5 Financiële Indicatiecode bij het staken van TA.|| MBH_300_SCRIPT5|| MBH_300_SCRIPT5_TA_STAKEN<br/>MBH_300_SCRIPT5_TA | ||
Regel 29: | Regel 31: | ||
| Scenario|| Screenshots?|| Beschrijving | | Scenario|| Screenshots?|| Beschrijving | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.1|| || <div>Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met | + | |0.1|| || <div>Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 5 toedieningsafspraken)</div> |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.2|| || <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div> | |0.2|| || <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div> | ||
Regel 35: | Regel 37: | ||
|0.3|| || <div>Toedieningsafspraken met een filter op productcode (HPK 1119265) (Antwoord: bericht met 1 toedieningsafspraak)<br/>Optioneel voor raadplegende systemen</div> | |0.3|| || <div>Toedieningsafspraken met een filter op productcode (HPK 1119265) (Antwoord: bericht met 1 toedieningsafspraak)<br/>Optioneel voor raadplegende systemen</div> | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.4|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-1) (Antwoord: bericht met | + | |0.4|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-1) (Antwoord: bericht met 2 toedieningsafspraken)</div> |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.5|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-11) (Antwoord: bericht met 3 toedieningsafspraken)</div> | |0.5|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-11) (Antwoord: bericht met 3 toedieningsafspraken)</div> | ||
Regel 41: | Regel 43: | ||
|0.6|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2 toedieningsafspraken)</div> | |0.6|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2 toedieningsafspraken)</div> | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.7|| || <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met | + | |0.7|| || <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met 2 toedieningsafspraken)</div> |
|} | |} | ||
<section end=overview-MGB-0 /> | <section end=overview-MGB-0 /> | ||
Regel 66: | Regel 68: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|3|| De TA die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_TA | |3|| De TA die wordt aangemaakt in script 3|| MBH_300_script3|| MBH_300_script3_TA | ||
+ | |-style="vertical-align:top;|style="background-color: white;" | ||
+ | |4|| De parallelle TA's die worden aangemaakt in script 4|| MBH_300_script4|| MBH_300_script4_TA_GDS<br/>MBH_300_script4_TA_los | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|5|| De TA bouwstenen van kwalificatiescript 5 Financiële Indicatiecode bij het staken van TA.|| MBH_300_SCRIPT5|| MBH_300_SCRIPT5_TA_STAKEN<br/>MBH_300_SCRIPT5_TA | |5|| De TA bouwstenen van kwalificatiescript 5 Financiële Indicatiecode bij het staken van TA.|| MBH_300_SCRIPT5|| MBH_300_SCRIPT5_TA_STAKEN<br/>MBH_300_SCRIPT5_TA | ||
Regel 78: | Regel 82: | ||
| Scenario|| Beschrijving | | Scenario|| Beschrijving | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.1|| <div>Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met | + | |0.1|| <div>Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 5 toedieningsafspraken)</div> |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.2|| <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div> | |0.2|| <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div> | ||
Regel 84: | Regel 88: | ||
|0.3|| <div>Toedieningsafspraken met een filter op productcode (HPK 1119265) (Antwoord: bericht met 1 toedieningsafspraak)<br/>Optioneel voor raadplegende systemen</div> | |0.3|| <div>Toedieningsafspraken met een filter op productcode (HPK 1119265) (Antwoord: bericht met 1 toedieningsafspraak)<br/>Optioneel voor raadplegende systemen</div> | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.4|| <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-1) (Antwoord: bericht met | + | |0.4|| <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-1) (Antwoord: bericht met 2 toedieningsafspraken)</div> |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.5|| <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-11) (Antwoord: bericht met 3 toedieningsafspraken)</div> | |0.5|| <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-11) (Antwoord: bericht met 3 toedieningsafspraken)</div> | ||
Regel 90: | Regel 94: | ||
|0.6|| <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2 toedieningsafspraken)</div> | |0.6|| <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2 toedieningsafspraken)</div> | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |0.7|| <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met | + | |0.7|| <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met 2 toedieningsafspraken)</div> |
|} | |} | ||
<section end=overview-MGR-0 /> | <section end=overview-MGR-0 /> | ||
Regel 168: | Regel 172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
Regel 184: | Regel 188: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
Regel 202: | Regel 206: | ||
|style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA1_TA_toekomstig |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 212: | Regel 214: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T - 10 dagen om | + | |style="background-color: white;"|T - 10 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, gedurende 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 233: | Regel 235: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 249: | Regel 251: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.7 ml 's ochtends, subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.7 ml 's ochtends |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 262: | Regel 264: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_MA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== Scenario 0.1 - | + | ==== Scenario 0.1 - MBH_300_script0_QA2==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 277: | Regel 279: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 09:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 298: | Regel 300: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ENOXAPARINE BECAT INJVLST 2.000IE (20MG)/0,2ML WW (code = '2807815' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ENOXAPARINE INJ SP 2000IE(20MG)=0,2ML(10.000IE/ML) (code = '146676' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ENOXAPARINE INJVLST 10.000IE/ML (100MG/ML) (code = '171816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 314: | Regel 316: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.2 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.2 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 327: | Regel 329: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== Scenario 0.1 - | + | ==== Scenario 0.1 - MBH_300_script0_QA3==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA3_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 342: | Regel 344: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 25 dagen, gedurende 2 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|2 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 360: | Regel 365: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 376: | Regel 381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 389: | Regel 394: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== | + | ==== Scenario 0.1 - MBH_300_script0_QA4==== |
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA4_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratie datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen om 11:15 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Gebruiksinstructie | |
− | |||
− | |||
− | |||
− | |||
− | |colspan=" | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Toedieningsweg |
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Organisatie naam |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-1 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-1 /> | ||
+ | == KWAL Medicatiegegevens TA Script0 (filterqueries)== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script0-v30-0-2 /><section begin=patient-mg-mp-mg-kwal-TA-script0-v30-0-2 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|G. |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"| | + | |colspan="3"|Naamgebruik |
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900596 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|1 nov 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | |} | + | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0-2 /><section begin=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-2 /> |
− | ==== | + | ==== Scenario 0.2 - MBH_300_script0_QA1==== |
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratie datum tijd |
− | + | |style="background-color: white;"|T - 20 dagen om 09:15 uur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background- | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="2"|Doseerinstructie | |
− | + | |style="background-color: white;"|1 maal per dag 0.7 ml | |
− | |colspan="2"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Organisatie naam |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-2 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-2 /> | ||
+ | == KWAL Medicatiegegevens TA Script0 (filterqueries)== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script0-v30-0-3 /><section begin=patient-mg-mp-mg-kwal-TA-script0-v30-0-3 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"| | + | |colspan="3"|Naamgebruik |
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900596 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|1 nov 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
− | |} | + | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0-3 /><section begin=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-3 /> |
− | ==== | + | ==== Scenario 0.3 - MBH_300_script0_QA4==== |
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA4_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Registratie datum tijd |
− | + | |style="background-color: white;"|T - 12 dagen om 11:15 uur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background- | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Gebruiksinstructie | |
− | |||
− | |||
− | |||
− | |||
− | |colspan=" | ||
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="2"|Omschrijving | |
− | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 750: | Regel 708: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
Regel 759: | Regel 717: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-3 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-3 /> | ||
== KWAL Medicatiegegevens TA Script0 (filterqueries)== | == KWAL Medicatiegegevens TA Script0 (filterqueries)== | ||
− | <section begin=mg-mp-mg-kwal-TA-script0-v30-0- | + | <section begin=mg-mp-mg-kwal-TA-script0-v30-0-4 /><section begin=patient-mg-mp-mg-kwal-TA-script0-v30-0-4 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 794: | Regel 755: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
− | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0- | + | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0-4 /><section begin=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-4 /> |
− | ==== Scenario 0. | + | ==== Scenario 0.4 - MBH_300_script0_QA4==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA4_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 805: | Regel 766: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 12 dagen om 11:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 12 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 826: | Regel 784: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 842: | Regel 800: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 855: | Regel 813: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== Scenario 0. | + | ==== Scenario 0.4 - MBH_300_script0_QA1==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA1_TA_toekomstig |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 870: | Regel 828: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, gedurende 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 891: | Regel 849: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 907: | Regel 865: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.7 ml 's ochtends, subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.7 ml 's ochtends |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 920: | Regel 878: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_MA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Organisatie naam |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-4 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-4 /> | ||
+ | == KWAL Medicatiegegevens TA Script0 (filterqueries)== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script0-v30-0-5 /><section begin=patient-mg-mp-mg-kwal-TA-script0-v30-0-5 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Initialen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900596 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 nov 1963 |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="4"|Geslacht | |
− | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |
− | |colspan=" | + | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0-5 /><section begin=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-5 /> |
− | |style="background-color: white;"| | + | ==== Scenario 0.5 - MBH_300_script0_QA1==== |
− | |- | + | |
− | |||
− | |||
− | |||
− | ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T - 20 dagen om 09:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Verstrekker | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |rowspan="2"| | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | |-style="background-color: # | + | |colspan="2"|Zorgaanbieder |
− | | | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|G | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 0.7 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario 0. | + | ==== Scenario 0.5 - MBH_300_script0_QA3==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.071: | Regel 1.035: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
Regel 1.087: | Regel 1.051: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.105: | Regel 1.069: | ||
|style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
− | ==== Scenario 0. | + | ==== Scenario 0.5 - MBH_300_script0_QA4==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 1.133: | Regel 1.097: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
Regel 1.149: | Regel 1.113: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.175: | Regel 1.139: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
Regel 1.184: | Regel 1.148: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-5 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-5 /> | ||
== KWAL Medicatiegegevens TA Script0 (filterqueries)== | == KWAL Medicatiegegevens TA Script0 (filterqueries)== | ||
− | <section begin=mg-mp-mg-kwal-TA-script0-v30-0- | + | <section begin=mg-mp-mg-kwal-TA-script0-v30-0-6 /><section begin=patient-mg-mp-mg-kwal-TA-script0-v30-0-6 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.219: | Regel 1.186: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
− | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0- | + | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0-6 /><section begin=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-6 /> |
− | ==== Scenario 0. | + | ==== Scenario 0.6 - MBH_300_script0_QA3==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA3_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.230: | Regel 1.197: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 25 dagen, gedurende 2 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.251: | Regel 1.218: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.267: | Regel 1.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.280: | Regel 1.247: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== | + | ==== Scenario 0.6 - MBH_300_script0_QA4==== |
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA4_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T - 12 dagen om 11:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 12 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 12 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-6 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-6 /> | ||
+ | == KWAL Medicatiegegevens TA Script0 (filterqueries)== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script0-v30-0-7 /><section begin=patient-mg-mp-mg-kwal-TA-script0-v30-0-7 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Naamgegevens |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Initialen |
+ | |style="background-color: white;"|G. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Achternaam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groot |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900596 [BSN] |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="4"|Geboortedatum |
+ | |style="background-color: white;"|1 nov 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="4"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
+ | |}<section end=patient-mg-mp-mg-kwal-TA-script0-v30-0-7 /><section begin=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-7 /> | ||
+ | ==== Scenario 0.7 - MBH_300_script0_QA1==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA1_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Registratie datum tijd | |
− | + | |style="background-color: white;"|T - 20 dagen om 09:15 uur | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.438: | Regel 1.401: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml, Subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 0.7 ml |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.473: | Regel 1.430: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script0_QA1_TA_toekomstig |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.493: | Regel 1.443: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_TA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 10 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, gedurende 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|5 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.517: | Regel 1.464: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.7 ml 's ochtends, subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.7 ml 's ochtends |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.549: | Regel 1.493: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1_MA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.562: | Regel 1.506: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
Regel 1.571: | Regel 1.515: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-mg-mp-mg-kwal-TA- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | == KWAL Medicatiegegevens TA script | + | |colspan="2"|Adresgegevens |
− | <section begin=mg-mp-mg-kwal-TA- | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script0-v30-0-7 /><section end=mg-mp-mg-kwal-TA-script0-v30-0-7 /> | ||
+ | == KWAL Medicatiegegevens TA script 1== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script1-v30-1 /><section begin=patient-mg-mp-mg-kwal-TA-script1-v30-1 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 1.583: | Regel 1.530: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|H |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 1.593: | Regel 1.540: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="2"| | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|de | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Huyser |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900663 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|7 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
− | |}<section end=patient-mg-mp-mg-kwal-TA- | + | |}<section end=patient-mg-mp-mg-kwal-TA-script1-v30-1 /><section begin=mbhs-mg-mp-mg-kwal-TA-script1-v30-1 /> |
− | ==== Scenario | + | ==== Scenario 1 - MBH_300_SCRIPT1==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_SCRIPT1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.617: | Regel 1.567: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_SCRIPT1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 08:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 21 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|21 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
Regel 1.635: | Regel 1.588: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.664: | Regel 1.620: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_SCRIPT1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_SCRIPT1_TA_WIJZIGING |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1_TA_WIJZIGING (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T + 20 dagen om 07:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 21 dagen, gedurende 18 weken'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|18 weken |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toedieningsafspraak reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="5"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Registratie datum tijd | + | |colspan="2"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"|T - 5 dagen om 09:15 uur | + | |style="background-color: white;"|21 dagen |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Gebruiksperiode | + | |colspan="4"|Relatie medicatieafspraak |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen'' | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1_MA_WIJZIGING (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie toedieningsafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_SCRIPT1_TA_STOP | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1_TA_STOP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T + 20 dagen om 07:30 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 20 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 20 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsafspraak stop type | ||
+ | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|21 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script1-v30-1 /><section end=mg-mp-mg-kwal-TA-script1-v30-1 /> | ||
+ | == KWAL Medicatiegegevens TA script 2== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script2-v30-2 /><section begin=patient-mg-mp-mg-kwal-TA-script2-v30-2 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|M | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Oorschot | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900869 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|31 okt 1985 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
+ | |}<section end=patient-mg-mp-mg-kwal-TA-script2-v30-2 /><section begin=mbhs-mg-mp-mg-kwal-TA-script2-v30-2 /> | ||
+ | ==== Scenario 2 - MBH_300_script2==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script2_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T - 40 dagen om 15:23 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 40 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 40 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Volgens schema trombosedienst, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_script2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script2-v30-2 /><section end=mg-mp-mg-kwal-TA-script2-v30-2 /> | ||
+ | == KWAL Medicatiegegevens TA script 3== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script3-v30-3 /><section begin=patient-mg-mp-mg-kwal-TA-script3-v30-3 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|H | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van de | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Kamphuis | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900675 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|8 nov 1963 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
+ | |}<section end=patient-mg-mp-mg-kwal-TA-script3-v30-3 /><section begin=mbhs-mg-mp-mg-kwal-TA-script3-v30-3 /> | ||
+ | ==== Scenario 3 - MBH_300_script3==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script3_TA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 09:15 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 15 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|NITROLINGUAL OROMUCOSALE SPRAY 0,4MG/DO FLAC 250DO (code = '704369' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO FL 250DO (code = '72214' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO (code = '119431' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Bij pijn 1 à 2 doses , maximaal 3 doses per dag, 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts., oromucosaal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oromucosaal (code = '34' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Bij pijn 1 à 2 doses , maximaal 3 doses per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_script3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Organisatie naam | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script3-v30-3 /><section end=mg-mp-mg-kwal-TA-script3-v30-3 /> | ||
+ | == KWAL Medicatiegegevens TA script 4== | ||
+ | <section begin=mg-mp-mg-kwal-TA-script4-v30-4 /><section begin=patient-mg-mp-mg-kwal-TA-script4-v30-4 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Initialen | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Roepnaam | ||
+ | |style="background-color: white;"|Themanager | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Braak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900651 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|25 jul 1954 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
+ | |}<section end=patient-mg-mp-mg-kwal-TA-script4-v30-4 /><section begin=mbhs-mg-mp-mg-kwal-TA-script4-v30-4 /> | ||
+ | ==== Scenario 4 - MBH_300_script4==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script4_TA_GDS | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script4_TA_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T - 6 dagen om 11:40 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen om 11:30 uur, gedurende 10 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 6 dagen om 11:30 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM AUROBINDO TABLET MSR 25MG (code = '630586' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '8060' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '22276' in codeSystem '<span title="2.16.840.1.113883.2.4.4.1">G-Standaard GPK</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|eerst gedurende 3 dagen elke dag om 08:00 en 22:00 2 stuks, dan gedurende 7 dagen elke dag om 08:00, 14:00 en 22:00 1 stuk, vóór het eten, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): vóór het eten | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 3 dagen elke dag om 08:00 en 22:00 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|dan gedurende 7 dagen elke dag om 08:00, 14:00 en 22:00 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|zo nodig medicatie wordt los verstrekt. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_300_script4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_script4_TA_los | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_300_script4_TA_los (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratie datum tijd | ||
+ | |style="background-color: white;"|T - 6 dagen om 11:40:01 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen om 11:30 uur, gedurende 10 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 6 dagen om 11:30 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Gebruiksduur | ||
+ | |style="background-color: white;"|10 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Verstrekker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|DICLOFENAC NATRIUM AUROBINDO TABLET MSR 25MG (code = '630586' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '8060' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '22276' in codeSystem '<span title="2.16.840.1.113883.2.4.4.1">G-Standaard GPK</span>') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 3 dagen Bij pijn elke dag om 14:00 2 stuks , maximaal 6 stuks per dag, dan gedurende 7 dagen Bij pijn elke dag om 14:00 1 stuk , maximaal 4 stuks per dag, vóór het eten, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Aanvullende instructie | |colspan="2"|Aanvullende instructie | ||
− | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): vóór het eten |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|eerst gedurende 3 dagen Bij pijn elke dag om 14:00 2 stuks , maximaal 6 stuks per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie 2 |
− | |style="background-color: white;"|Bij pijn 1 | + | |style="background-color: white;"|dan gedurende 7 dagen Bij pijn elke dag om 14:00 1 stuk , maximaal 4 stuks per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Relatie medicatieafspraak | |colspan="4"|Relatie medicatieafspraak | ||
Regel 1.788: | Regel 2.212: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_script4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
Regel 1.801: | Regel 2.225: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
Regel 1.810: | Regel 2.234: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |}<section end=mbhs-mg-mp-mg-kwal-TA- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-kwal-TA-script4-v30-4 /><section end=mg-mp-mg-kwal-TA-script4-v30-4 /> | ||
== KWAL Medicatiegegevens TA script 5== | == KWAL Medicatiegegevens TA script 5== | ||
<section begin=mg-mp-mg-kwal-TA-script5-b-v30-5 /><section begin=patient-mg-mp-mg-kwal-TA-script5-b-v30-5 /> | <section begin=mg-mp-mg-kwal-TA-script5-b-v30-5 /><section begin=patient-mg-mp-mg-kwal-TA-script5-b-v30-5 /> | ||
Regel 1.859: | Regel 2.286: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 2 dagen om 09:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak stop type | |colspan="3"|Toedieningsafspraak stop type | ||
Regel 1.880: | Regel 2.307: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsafspraak reden wijzigen of staken | |colspan="3"|Toedieningsafspraak reden wijzigen of staken | ||
Regel 1.899: | Regel 2.326: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.935: | Regel 2.362: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratie datum tijd | |colspan="3"|Registratie datum tijd | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, gedurende 6 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
− | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
Regel 1.953: | Regel 2.380: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
− | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
Regel 1.969: | Regel 2.396: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 1.995: | Regel 2.422: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder identificatienummer | |colspan="2"|Zorgaanbieder identificatienummer | ||
Regel 2.004: | Regel 2.431: | ||
|colspan="2"|Organisatie naam | |colspan="2"|Organisatie naam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-kwal-TA-script5-b-v30-5 /><section end=mg-mp-mg-kwal-TA-script5-b-v30-5 /> | |}<section end=mbhs-mg-mp-mg-kwal-TA-script5-b-v30-5 /><section end=mg-mp-mg-kwal-TA-script5-b-v30-5 /> | ||
== KWAL Medicatiegegevens TA script 6 (geen medicatie)== | == KWAL Medicatiegegevens TA script 6 (geen medicatie)== |
Huidige versie van 22 nov 2024 om 15:40
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
- 1.3 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.4 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.5 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.6 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.7 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.8 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.9 KWAL Medicatiegegevens TA Script0 (filterqueries)
- 1.10 KWAL Medicatiegegevens TA script 1
- 1.11 KWAL Medicatiegegevens TA script 2
- 1.12 KWAL Medicatiegegevens TA script 3
- 1.13 KWAL Medicatiegegevens TA script 4
- 1.14 KWAL Medicatiegegevens TA script 5
- 1.15 KWAL Medicatiegegevens TA script 6 (geen medicatie)
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset
Scenario | Screenshots? | Beschrijving | MBH id | TA id |
1 | De TA bouwstenen van kwalificatiescript 1 Chemotherapie - Herhaal Cyclisch Schema |
MBH_300_SCRIPT1 | MBH_300_SCRIPT1_TA MBH_300_SCRIPT1_TA_WIJZIGING MBH_300_SCRIPT1_TA_STOP | |
2 | De toedieningsafspraak bouwsteen van kwalificatiescript 2 wisselend doseerschemas | MBH_300_script2 | MBH_300_script2_TA | |
3 | Maak screenshot(s) van de TA waaruit blijkt dat een aanvullende instructie, en gebruiksinstructie zo nodig correct wordt verwerkt/getoond. | De TA die wordt aangemaakt in script 3 | MBH_300_script3 | MBH_300_script3_TA |
4 | Maak screenshot(s) van de TA waaruit blijkt dat de gebruiksinstructie correct wordt verwerkt/getoond. | De parallelle TA's die worden aangemaakt in script 4 | MBH_300_script4 | MBH_300_script4_TA_GDS MBH_300_script4_TA_los |
5 | Laat zien dat de TA gestaakt wordt door de stop-TA | De TA bouwstenen van kwalificatiescript 5 Financiële Indicatiecode bij het staken van TA. | MBH_300_SCRIPT5 | MBH_300_SCRIPT5_TA_STAKEN MBH_300_SCRIPT5_TA |
1.1.2 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
Scenario | Screenshots? | Beschrijving |
0.1 | Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 5 toedieningsafspraken)
| |
0.2 | Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)
| |
0.3 | Toedieningsafspraken met een filter op productcode (HPK 1119265) (Antwoord: bericht met 1 toedieningsafspraak)
Optioneel voor raadplegende systemen | |
0.4 | Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-1) (Antwoord: bericht met 2 toedieningsafspraken)
| |
0.5 | Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-11) (Antwoord: bericht met 3 toedieningsafspraken)
| |
0.6 | Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2 toedieningsafspraken)
| |
0.7 | Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met 2 toedieningsafspraken)
|
1.1.3 Scenarioset 14
Scenario | Screenshots? | Beschrijving | MBH id | TA id |
14.1 | Een antwoord zonder toedieningsafspraken |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset
Scenario | Beschrijving | MBH id | TA id |
1 | De TA bouwstenen van kwalificatiescript 1 Chemotherapie - Herhaal Cyclisch Schema |
MBH_300_SCRIPT1 | MBH_300_SCRIPT1_TA MBH_300_SCRIPT1_TA_WIJZIGING MBH_300_SCRIPT1_TA_STOP |
2 | De toedieningsafspraak bouwsteen van kwalificatiescript 2 wisselend doseerschemas | MBH_300_script2 | MBH_300_script2_TA |
3 | De TA die wordt aangemaakt in script 3 | MBH_300_script3 | MBH_300_script3_TA |
4 | De parallelle TA's die worden aangemaakt in script 4 | MBH_300_script4 | MBH_300_script4_TA_GDS MBH_300_script4_TA_los |
5 | De TA bouwstenen van kwalificatiescript 5 Financiële Indicatiecode bij het staken van TA. | MBH_300_SCRIPT5 | MBH_300_SCRIPT5_TA_STAKEN MBH_300_SCRIPT5_TA |
1.2.2 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
Scenario | Beschrijving |
0.1 | Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 5 toedieningsafspraken)
|
0.2 | Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)
|
0.3 | Toedieningsafspraken met een filter op productcode (HPK 1119265) (Antwoord: bericht met 1 toedieningsafspraak)
Optioneel voor raadplegende systemen |
0.4 | Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-1) (Antwoord: bericht met 2 toedieningsafspraken)
|
0.5 | Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-11) (Antwoord: bericht met 3 toedieningsafspraken)
|
0.6 | Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-14 tot en met T-11) (Antwoord: bericht met 2 toedieningsafspraken)
|
0.7 | Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_script0_QA1" invoeren) (Antwoord: bericht met 2 toedieningsafspraken)
|
1.2.3 Scenarioset 14
Scenario | Beschrijving | MBH id | TA id |
14.1 | Een antwoord zonder toedieningsafspraken |
1.3 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.3.1 Scenario 0.1 - MBH_300_script0_QA1
Toedieningsafspraak MBH_300_script0_QA1_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 20 dagen om 09:15 uur | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_300_script0_QA1_TA_toekomstig | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 10 dagen om 11:30 uur | ||
Gebruiksperiode | Vanaf T + 5 dagen, gedurende 5 dagen | ||
Ingangsdatum | T + 5 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 0.7 ml 's ochtends, subcutaan | ||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 0.7 ml 's ochtends | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.2 Scenario 0.1 - MBH_300_script0_QA2
Toedieningsafspraak MBH_300_script0_QA2_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 10 dagen om 09:18 uur | ||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 3 dagen | ||
Ingangsdatum | T - 10 dagen | ||
Einddatum | T - 3 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ENOXAPARINE BECAT INJVLST 2.000IE (20MG)/0,2ML WW (code = '2807815' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ENOXAPARINE INJ SP 2000IE(20MG)=0,2ML(10.000IE/ML) (code = '146676' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ENOXAPARINE INJVLST 10.000IE/ML (100MG/ML) (code = '171816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.2 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 0.2 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.3 Scenario 0.1 - MBH_300_script0_QA3
Toedieningsafspraak MBH_300_script0_QA3_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 25 dagen om 11:20 uur | ||
Gebruiksperiode | Vanaf T - 25 dagen, gedurende 2 weken | ||
Ingangsdatum | T - 25 dagen | ||
Gebruiksduur | 2 weken | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.4 Scenario 0.1 - MBH_300_script0_QA4
Toedieningsafspraak MBH_300_script0_QA4_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 12 dagen om 11:15 uur | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.5 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.4 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.4.1 Scenario 0.2 - MBH_300_script0_QA1
Toedieningsafspraak MBH_300_script0_QA1_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 20 dagen om 09:15 uur | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.5 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.5.1 Scenario 0.3 - MBH_300_script0_QA4
Toedieningsafspraak MBH_300_script0_QA4_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 12 dagen om 11:15 uur | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.6 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.6.1 Scenario 0.4 - MBH_300_script0_QA4
Toedieningsafspraak MBH_300_script0_QA4_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 12 dagen om 11:15 uur | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.2 Scenario 0.4 - MBH_300_script0_QA1
Toedieningsafspraak MBH_300_script0_QA1_TA_toekomstig | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 10 dagen om 11:30 uur | ||
Gebruiksperiode | Vanaf T + 5 dagen, gedurende 5 dagen | ||
Ingangsdatum | T + 5 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 0.7 ml 's ochtends, subcutaan | ||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 0.7 ml 's ochtends | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.3 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.7 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.7.1 Scenario 0.5 - MBH_300_script0_QA1
Toedieningsafspraak MBH_300_script0_QA1_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 20 dagen om 09:15 uur | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.2 Scenario 0.5 - MBH_300_script0_QA3
Toedieningsafspraak MBH_300_script0_QA3_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 25 dagen om 11:20 uur | ||
Gebruiksperiode | Vanaf T - 25 dagen, gedurende 2 weken | ||
Ingangsdatum | T - 25 dagen | ||
Gebruiksduur | 2 weken | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.3 Scenario 0.5 - MBH_300_script0_QA4
Toedieningsafspraak MBH_300_script0_QA4_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 12 dagen om 11:15 uur | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.4 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.8 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.8.1 Scenario 0.6 - MBH_300_script0_QA3
Toedieningsafspraak MBH_300_script0_QA3_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 25 dagen om 11:20 uur | ||
Gebruiksperiode | Vanaf T - 25 dagen, gedurende 2 weken | ||
Ingangsdatum | T - 25 dagen | ||
Gebruiksduur | 2 weken | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.2 Scenario 0.6 - MBH_300_script0_QA4
Toedieningsafspraak MBH_300_script0_QA4_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 12 dagen om 11:15 uur | ||
Gebruiksperiode | Vanaf T - 12 dagen | ||
Ingangsdatum | T - 12 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | FENPROCOUMON TABLET 3MG (code = '1119265' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.3 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.9 KWAL Medicatiegegevens TA Script0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | G. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Groot | |||
Identificatienummer | 999900596 [BSN] | |||
Geboortedatum | 1 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.9.1 Scenario 0.7 - MBH_300_script0_QA1
Toedieningsafspraak MBH_300_script0_QA1_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 20 dagen om 09:15 uur | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 5 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 0.7 ml, Subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 0.7 ml | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_300_script0_QA1_TA_toekomstig | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script0_QA1_TA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 10 dagen om 11:30 uur | ||
Gebruiksperiode | Vanaf T + 5 dagen, gedurende 5 dagen | ||
Ingangsdatum | T + 5 dagen | ||
Gebruiksduur | 5 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | INNOHEP INJVLST 20000 IE/ML WWSP 0,7ML (code = '1108751' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVL WWSP 14000IE=0,7ML (20.000IE/ML) (code = '49255' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TINZAPARINE INJVLST 20.000IE/ML (code = '103888' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 0.7 ml 's ochtends, subcutaan | ||
Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 0.7 ml 's ochtends | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script0_QA1_MA_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script0_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.10 KWAL Medicatiegegevens TA script 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | H | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Voorvoegsels | de | |||
Achternaam | XXX_Huyser | |||
Identificatienummer | 999900663 [BSN] | |||
Geboortedatum | 7 nov 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.10.1 Scenario 1 - MBH_300_SCRIPT1
Toedieningsafspraak MBH_300_SCRIPT1_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_SCRIPT1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T om 08:30 uur | ||
Gebruiksperiode | Vanaf T, gedurende 21 weken | ||
Ingangsdatum | T | ||
Gebruiksduur | 21 weken | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden | ||
Herhaalperiode cyclisch schema | 21 dagen | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_SCRIPT1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_300_SCRIPT1_TA_WIJZIGING | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_SCRIPT1_TA_WIJZIGING (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T + 20 dagen om 07:30 uur | ||
Gebruiksperiode | Vanaf T + 21 dagen, gedurende 18 weken | ||
Ingangsdatum | T + 21 dagen | ||
Gebruiksduur | 18 weken | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Toedieningsafspraak reden wijzigen of staken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - primaire code | ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | gedurende 14 dagen elke dag om 09:00 en 21:00 5 stuks - let op, tijden exact aanhouden | ||
Herhaalperiode cyclisch schema | 21 dagen | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_SCRIPT1_MA_WIJZIGING (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_SCRIPT1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_300_SCRIPT1_TA_STOP | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_SCRIPT1_TA_STOP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T + 20 dagen om 07:30 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 20 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 20 dagen | ||
Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ECANSYA TABLET FILMOMHULD 500MG (code = '3060195' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '59366' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CAPECITABINE TABLET FO 500MG (code = '112984' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | cyclus van 21 dagen: steeds gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | gedurende 14 dagen elke dag om 09:00 en 21:00 4 stuks - let op, tijden exact aanhouden | ||
Herhaalperiode cyclisch schema | 21 dagen | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_SCRIPT1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_SCRIPT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.10.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.11 KWAL Medicatiegegevens TA script 2
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Oorschot | |||
Identificatienummer | 999900869 [BSN] | |||
Geboortedatum | 31 okt 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.11.1 Scenario 2 - MBH_300_script2
Toedieningsafspraak MBH_300_script2_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 40 dagen om 15:23 uur | ||
Gebruiksperiode | Vanaf T - 40 dagen | ||
Ingangsdatum | T - 40 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Volgens schema trombosedienst, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.11.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.12 KWAL Medicatiegegevens TA script 3
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | H | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Kamphuis | |||
Identificatienummer | 999900675 [BSN] | |||
Geboortedatum | 8 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.12.1 Scenario 3 - MBH_300_script3
Toedieningsafspraak MBH_300_script3_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 5 dagen om 09:15 uur | ||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 15 dagen | ||
Ingangsdatum | T - 5 dagen | ||
Einddatum | T + 15 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | NITROLINGUAL OROMUCOSALE SPRAY 0,4MG/DO FLAC 250DO (code = '704369' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO FL 250DO (code = '72214' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO (code = '119431' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Bij pijn 1 à 2 doses , maximaal 3 doses per dag, 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts., oromucosaal | ||
Toedieningsweg | oromucosaal (code = '34' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): 1-2 doses onder de tong, na 5-10 min herhalen, max. 3 opeenvolgende doses. Bij onvoldoende effect na in totaal 3 doses direct contact opnemen met een arts. | ||
Doseerinstructie | Bij pijn 1 à 2 doses , maximaal 3 doses per dag | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.12.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.13 KWAL Medicatiegegevens TA script 4
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | T | |||
Roepnaam | Themanager | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Braak | |||
Identificatienummer | 999900651 [BSN] | |||
Geboortedatum | 25 jul 1954 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.13.1 Scenario 4 - MBH_300_script4
Toedieningsafspraak MBH_300_script4_TA_GDS | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script4_TA_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 6 dagen om 11:40 uur | ||
Gebruiksperiode | Vanaf T - 6 dagen om 11:30 uur, gedurende 10 dagen | ||
Ingangsdatum | T - 6 dagen om 11:30 uur | ||
Gebruiksduur | 10 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM AUROBINDO TABLET MSR 25MG (code = '630586' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '8060' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '22276' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | eerst gedurende 3 dagen elke dag om 08:00 en 22:00 2 stuks, dan gedurende 7 dagen elke dag om 08:00, 14:00 en 22:00 1 stuk, vóór het eten, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): vóór het eten | ||
Doseerinstructie 1 | eerst gedurende 3 dagen elke dag om 08:00 en 22:00 2 stuks | ||
Doseerinstructie 2 | dan gedurende 7 dagen elke dag om 08:00, 14:00 en 22:00 1 stuk | ||
Toelichting | zo nodig medicatie wordt los verstrekt. | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_300_script4_TA_los | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_script4_TA_los (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T - 6 dagen om 11:40:01 uur | ||
Gebruiksperiode | Vanaf T - 6 dagen om 11:30 uur, gedurende 10 dagen | ||
Ingangsdatum | T - 6 dagen om 11:30 uur | ||
Gebruiksduur | 10 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | DICLOFENAC NATRIUM AUROBINDO TABLET MSR 25MG (code = '630586' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '8060' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DICLOFENAC-NATRIUM TABLET MSR 25MG (code = '22276' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | eerst gedurende 3 dagen Bij pijn elke dag om 14:00 2 stuks , maximaal 6 stuks per dag, dan gedurende 7 dagen Bij pijn elke dag om 14:00 1 stuk , maximaal 4 stuks per dag, vóór het eten, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): vóór het eten | ||
Doseerinstructie 1 | eerst gedurende 3 dagen Bij pijn elke dag om 14:00 2 stuks , maximaal 6 stuks per dag | ||
Doseerinstructie 2 | dan gedurende 7 dagen Bij pijn elke dag om 14:00 1 stuk , maximaal 4 stuks per dag | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_script4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_script4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.13.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.14 KWAL Medicatiegegevens TA script 5
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | I | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Klerk | |||
Identificatienummer | 999900699 [BSN] | |||
Geboortedatum | 9 nov 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.14.1 Scenario 5 - MBH_300_SCRIPT5
Toedieningsafspraak MBH_300_SCRIPT5_TA_STAKEN | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_SCRIPT5_TA_STAKEN (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T + 2 dagen om 09:20 uur | ||
Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 2 dagen | ||
Ingangsdatum | T - 1 dag | ||
Einddatum | T + 2 dagen | ||
Toedieningsafspraak stop type | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Toedieningsafspraak reden wijzigen of staken | ongewenste reactie op medicatie en/of drugs (code = '62014003' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - primaire code | TEMAZEPAM AUROBINDO CAPSULE 20MG (code = '611662' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TEMAZEPAM CAPSULE 20MG (code = '15814' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TEMAZEPAM CAPSULE 20MG (code = '38644' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_SCRIPT5_MA_STAKEN (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Relatie toedieningsafspraak | |||
Identificatie | MBH_300_SCRIPT5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
MBH identificatie | MBH_300_SCRIPT5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Toedieningsafspraak MBH_300_SCRIPT5_TA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_300_SCRIPT5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Registratie datum tijd | T om 09:00 uur | ||
Gebruiksperiode | Vanaf T - 1 dag, gedurende 6 dagen | ||
Ingangsdatum | T - 1 dag | ||
Gebruiksduur | 6 dagen | ||
Verstrekker | |||
Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
Geneesmiddel - primaire code | TEMAZEPAM AUROBINDO CAPSULE 20MG (code = '611662' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | TEMAZEPAM CAPSULE 20MG (code = '15814' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | TEMAZEPAM CAPSULE 20MG (code = '38644' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_300_SCRIPT5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_300_SCRIPT5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.14.2 Bouwstenen
Bouwstenen | |||
Gegevenselement | Waarde | ||
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
Zorgaanbieder identificatienummer | 01236578 (in identificerend systeem: URA) | ||
Organisatie naam | Apotheek De Gulle Gaper | ||
Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
1.15 KWAL Medicatiegegevens TA script 6 (geen medicatie)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | W. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Verwijmeren | |||
Identificatienummer | 999901175 [BSN] | |||
Geboortedatum | 28 nov 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |